PLoS medicine, 2017-04, Vol.14 (4), p.e1002276-e1002276
2017
Details
- Autor(en) / Beteiligte
- Titel
- An open source pharma roadmap
- Ist Teil von
- PLoS medicine, 2017-04, Vol.14 (4), p.e1002276-e1002276
- Ort / Verlag
- United States: Public Library of Science
- Erscheinungsjahr
- 2017
- Link zum Volltext
- Quelle
- EZB Free E-Journals
- Beschreibungen/Notizen
- In an Essay, Matthew Todd and colleagues discuss an open source approach to drug development.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1549-1676, 1549-1277eISSN: 1549-1676DOI: 10.1371/journal.pmed.1002276Titel-ID: cdi_plos_journals_1899332014
- Format
- –
- Schlagworte
- Abbreviations, African trypanosomiasis, Alzheimer's disease, Analysis, Antimicrobial resistance, Artesunate, Business law, Cancer, Clinical trials, Commercialization, Community participation, Competition, Competitive Behavior, Computer and Information Sciences, Consumer Advocacy - standards, Data processing, Drug development, Drug discovery, Drug Discovery - economics, Drug Discovery - methods, Drug Discovery - organization & administration, Drug Industry - economics, Drug Industry - methods, Drug Industry - organization & administration, Health risks, Humans, India, Innovations, Life sciences, Malaria, Medicine and Health Sciences, Models, Theoretical, Neurodegenerative diseases, Nitroimidazole, Open source software, Organizations, Nonprofit, Pharmaceutical industry, Pharmaceutical Preparations - supply & distribution, Product development, Public health, R&D, Rectum, Research & development, Research - economics, Research - organization & administration, Reviews, Risk assessment, Science Policy, Social Sciences, Software, Specialization, Translation, Tropical diseases, Tuberculosis, Visceral leishmaniasis